196 related articles for article (PubMed ID: 34134639)
21. Neuropsychiatric Derangement by Polycythemia Vera: A Case Report of an Unexpected Disease Presentation and Review of the Literature.
De Lil H; van Beek M; Herbers A; van der Holst E; Keijsers K
Acta Haematol; 2021; 144(6):706-711. PubMed ID: 34247161
[TBL] [Abstract][Full Text] [Related]
22. Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
Ohyashiki K; Akahane D; Gotoh A; Ito Y; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
Leukemia; 2007 Dec; 21(12):2544-5. PubMed ID: 17611562
[No Abstract] [Full Text] [Related]
23. Extensive Hepatic Infarction due to Polycythemia Vera.
Furukawa K; Urano F; Okamura S; Kawashima H
J Gastrointestin Liver Dis; 2024 Mar; 33(1):18. PubMed ID: 38554424
[TBL] [Abstract][Full Text] [Related]
24. Thrombosis among 1537 patients with JAK2
Zhang Y; Zhou Y; Wang Y; Teng G; Li D; Wang Y; Du C; Chen Y; Zhang H; Li Y; Fu L; Chen K; Bai J
Cancer Med; 2020 Mar; 9(6):2096-2105. PubMed ID: 31994332
[TBL] [Abstract][Full Text] [Related]
25. Polycythemia vera and the Jak2(V617F) mutation in a case of hereditary spherocytosis.
Fleischman RA
Am J Med Sci; 2013 Oct; 346(4):328-30. PubMed ID: 23588264
[TBL] [Abstract][Full Text] [Related]
26. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
Zhan H; Spivak JL
Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
[TBL] [Abstract][Full Text] [Related]
27. JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I.
Berman JN; Greer WL; Archambeault S; Loh ML; Riddell C; Morash B; Dumas N; Fernandez CV; Ludman MD
Pediatr Blood Cancer; 2008 Nov; 51(5):689-91. PubMed ID: 18623221
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients.
Krečak I; Holik H; Zekanović I; Morić Perić M; Marketin T; Coha B; Gverić-Krečak V; Vodanović M; Lucijanić M
Thromb Res; 2022 Jan; 209():47-50. PubMed ID: 34864474
[No Abstract] [Full Text] [Related]
29. Compound in-cis JAK2 mutant polycythemia vera manifesting as first-onset transient ischemic attack with erythrocytosis and an attenuated JAK2 V617F mutant signal on a quantitative DD-PCR assay.
Ng IKS; Lee PL; Ng LJ; Chua RP; Ng YA; Lee CK; Tan JG; Chan THM; Yan B; Prasad V
Int J Lab Hematol; 2023 Apr; 45(2):e28-e31. PubMed ID: 36205319
[No Abstract] [Full Text] [Related]
30. JAK2 V617F mutation testing in polycythemia vera: use and impact in an academic practice.
Means RT
Am J Med Sci; 2008 Oct; 336(4):327-9. PubMed ID: 18854675
[TBL] [Abstract][Full Text] [Related]
31. Isolated cerebellar infarction as a presenting symptom of polycythemia vera.
Hilzenrat N; Zilberman D; Sikuler E
Acta Haematol; 1992; 88(4):204-6. PubMed ID: 1292311
[TBL] [Abstract][Full Text] [Related]
32. A resequencing program in India detects the rare JAK2 L579F mutation in patients suffering from polycythemia vera and negative for JAK2 V617F.
Acharya A; Vaniawala S; Parekh H; Sheikh H; Patel H; Ali R; Khan A; Nagee A; Kunjadia P; Mukhopadhyaya PN
Int J Lab Hematol; 2014 Aug; 36(4):e30-3. PubMed ID: 24033912
[No Abstract] [Full Text] [Related]
33. [Thrombosis in myeloproliferative neoplasms].
Asakura H
Rinsho Ketsueki; 2018; 59(8):1034-1041. PubMed ID: 30185703
[TBL] [Abstract][Full Text] [Related]
34. Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation.
Shen HX; Huang XQ; Fan CQ; Cao YX; Zhao H; Duan JG
Chin Med J (Engl); 2021 May; 134(10):1251-1253. PubMed ID: 33941751
[No Abstract] [Full Text] [Related]
35. B-cell acute lymphoblastic leukemia in JAK2 V617F-positive polycythemia vera.
Jaitly V; Wang W
Blood; 2018 Feb; 131(8):941. PubMed ID: 29472375
[No Abstract] [Full Text] [Related]
36. Concurrent JAK2(V617F) mutation and MTHFR(C677T) homozygosity in an adolescent with polycythemia vera: case report and discussion.
Ehmann MR; Goodenough CJ; Lotterman CD; Warrier RP
Clin Pediatr (Phila); 2013 Jul; 52(7):671-4. PubMed ID: 22626845
[No Abstract] [Full Text] [Related]
37. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.
Yoo JH; Park TS; Maeng HY; Sun YK; Kim YA; Kie JH; Cho EH; Song J; Lee KA; Suh B; Choi JR
Cancer Genet Cytogenet; 2009 Feb; 189(1):43-7. PubMed ID: 19167611
[TBL] [Abstract][Full Text] [Related]
38. Transformation of polycythemia vera to chronic myelogenous leukemia.
Mirza I; Frantz C; Clarke G; Voth AJ; Turner R
Arch Pathol Lab Med; 2007 Nov; 131(11):1719-24. PubMed ID: 17979493
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and Management of Cerebral Venous Thrombosis Due to Polycythemia Vera and Genetic Thrombophilia: Case Report and Literature Review.
Jianu DC; Jianu SN; Iacob N; Dan TF; Munteanu G; Gogu AE; Sadik R; Motoc AGM; Axelerad A; Sirbu CA; Petrica L; Ionita I
Life (Basel); 2023 Apr; 13(5):. PubMed ID: 37240720
[TBL] [Abstract][Full Text] [Related]
40. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
Reikvam H; Tiu RV
Leukemia; 2012 Apr; 26(4):563-71. PubMed ID: 22076463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
